Dr. Tesha Monteith discusses the Brain & Life article, “Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders?” by Hallie Levine, available in the latest issue of Brain & Life or at brainandlife.org.  Show reference: <a href= "https://www.brainandlife.org/articles/new-weight-loss-drugs-may-help-neurologic-disorders"> https://www.brainandlife.org/articles/new-weight-loss-drugs-may-help-neurologic-disorders</a>

<description>&lt;p&gt;Dr. Tesha Monteith discusses the Brain &amp; Life article, “Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders?” by Hallie Levine, available in the latest issue of Brain &amp; Life or at brainandlife.org. &lt;/p&gt; &lt;p&gt;Show reference:&lt;/p&gt; &lt;p&gt;&lt;a href= "https://www.brainandlife.org/articles/new-weight-loss-drugs-may-help-neurologic-disorders"&gt; https://www.brainandlife.org/articles/new-weight-loss-drugs-may-help-neurologic-disorders&lt;/a&gt; &lt;/p&gt;</description>

Dr. Tesha Monteith discusses the Brain & Life article, “Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders?” by Hallie Levine, available in the latest issue of Brain & Life or at brainandlife.org.  Show reference:...

Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders?

In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss how to differentiate between CAA-RI and PACNS. Show reference: <a href= "https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548">https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548</a>

<description>&lt;p&gt;In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss how to differentiate between CAA-RI and PACNS.&lt;/p&gt; &lt;p&gt;Show reference: &lt;a href= "https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548"&gt;https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548&lt;/a&gt; &lt;/p&gt;</description>

In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss how to differentiate between CAA-RI and PACNS. Show reference:  

CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 3

Dr. Gregg Day and Dr. Kathryn T. Hall discuss the complexities of the placebo effect, its variability among patients, and the genetic factors that influence responses to placebo treatments.

<description>&lt;p&gt;Dr. Gregg Day and Dr. Kathryn T. Hall discuss the complexities of the placebo effect, its variability among patients, and the genetic factors that influence responses to placebo treatments. &lt;/p&gt;</description>

Dr. Gregg Day and Dr. Kathryn T. Hall discuss the complexities of the placebo effect, its variability among patients, and the genetic factors that influence responses to placebo treatments. 

The Placebo Effect

In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss the underlying pathophysiology and how to diagnose primary angiitis of the CNS in clinical practice. Show reference: <a href= "https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548" target="_blank" rel= "noopener">https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548</a>

<description>&lt;p&gt;In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss the underlying pathophysiology and how to diagnose primary angiitis of the CNS in clinical practice.&lt;/p&gt; &lt;p&gt;Show reference: &lt;a href= "https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548" target="_blank" rel= "noopener"&gt;https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548&lt;/a&gt; &lt;/p&gt;</description>

In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss the underlying pathophysiology and how to diagnose primary angiitis of the CNS in clinical practice. Show reference:  

CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 2

In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss how cerebral amyloid angiopathy and CAA-RI present in clinical practice and how to make a diagnosis. Show reference: <a href= "https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548" target="_blank" rel= "noopener">https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548</a>

<description>&lt;p&gt;In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss how cerebral amyloid angiopathy and CAA-RI present in clinical practice and how to make a diagnosis.&lt;/p&gt; &lt;p&gt;Show reference:&lt;/p&gt; &lt;p&gt;&lt;a href= "https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548" target="_blank" rel= "noopener"&gt;https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548&lt;/a&gt; &lt;/p&gt;</description>

In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss how cerebral amyloid angiopathy and CAA-RI present in clinical practice and how to make a diagnosis. Show reference:  

CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 1

The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.

Neurology Minute

Details

Recent Episodes